Reuters
* OPKO HEALTH’S BIOREFERENCE LABORATORIES IN PARTNERSHIP WITH NEW YORK STATE INITIATES TESTING FOR COVID-19 ANTIBODIES
* BIOREFERENCE LABORATORIES – BEGINNING TODAY, WILL OFFER ANTIBODY BLOOD TESTS TO DETECT IMMUNE RESPONSE AFTER INFECTION WITH COVID-19 VIRUS
* BIOREFERENCE LABORATORIES – TO OFFER ANTIBODY BLOOD TESTS TO DETECT IMMUNE RESPONSE AFTER INFECTION WITH COVID-19 VIRUS
* BIOREFERENCE LABORATORIES – WORKING EXPEDITIOUSLY TO BE ABLE TO TEST 400,000 PATIENTS PER DAY BY MID-MAY.
* BIOREFERENCE LABORATORIES – THIS WEEK, CO LAUNCHES COVID-19 ANTIBODY TESTING NATIONWIDE
* BIOREFERENCE LABORATORIES – WORKING EXPEDITIOUSLY TO BE ABLE TO TEST 400,000 PATIENTS PER DAY BY MID-MAY S
Click here for original post on Reuters
